See also this year's filing and all EDGAR filings for this company.
PDF Report 0001637715_2022_Reneo_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001637715, Reneo Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 153,734,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 212,000 |
| 3 | remainder_Assets | 78,000 |
| 4 | LiabilitiesCurrent | 6,202,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 611,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,649,000 |
| 9 | ResearchAndDevelopmentExpense | 28,169,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 48,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 34,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 154,024,000 |
| 1 | Liabilities | 6,813,000 |
| 2 | Expenses | 39,818,000 |
| 3 | Revenues | 48,000 |
| 4 | StockholdersEquity | 147,211,000 |
| 5 | NetIncome | -39,770,000 |
| 6 | ComprehensiveNetIncome | -39,753,000 |
| 7 | BaseVar | 100,368,500 |
| 8 | EconomicCapitalRatio | 2.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
